Moviprep Appelsin

Polyethylene glycol 3350, the active ingredient in Moviprep Appelsin, is an osmotic laxative presented as an oral solution for oral use. It is indicated for bowel cleansing before colonoscopy and sigmoidoscopy, helping to evacuate the intestinal contents in adult patients.

GNH USA supplies Moviprep Appelsin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for bowel preparation agents in compliance with EU standards. The company ensures quality control, proper documentation and timely delivery to meet the needs of healthcare providers across multiple regions.

Moviprep Appelsin, an osmotic laxative, is used for bowel cleansing in preparation for gastrointestinal endoscopic procedures. - Colonoscopy: provides thorough bowel cleansing to allow clear visualization of the colon. - Sigmoidoscopy: prepares the lower gastrointestinal tract for accurate examination. - CT colonography: ensures adequate intestinal evacuation for optimal imaging results.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Abdominal bloating: sensation of fullness or distension. - Abdominal pain or cramps: intermittent discomfort. - Vomiting: occasional expulsion of stomach contents. - Thirst: increased desire for fluids. - Mild electrolyte imbalance: transient changes in sodium or potassium levels.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Significant electrolyte disturbances: such as hyponatremia or hypokalemia. - Renal impairment: reduced kidney function in susceptible individuals. - Allergic reactions: rash, itching, or swelling. - Colonic perforation: extremely rare but life‑threatening event.

Before using Moviprep Appelsin, consider the following precautions: - Renal function assessment: avoid in patients with severe renal impairment. - Electrolyte monitoring: check serum electrolytes in patients with cardiac disease or on diuretics. - Elderly patients: use with caution due to higher risk of dehydration. - Contraindications: do not use in cases of intestinal obstruction or perforation. - Concomitant laxatives: avoid simultaneous use with other strong laxatives. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Moviprep Appelsin may interact with other medications as follows: Major Interactions (Avoid): - Other osmotic laxatives (e.g., magnesium citrate): risk of severe electrolyte imbalance. - Loop diuretics: increased risk of dehydration and hypokalemia. - ACE inhibitors or ARBs: potential for renal dysfunction with volume depletion. - NSAIDs: heightened risk of renal injury. - High‑dose potassium supplements: may exacerbate hyperkalemia. Moderate Interactions (Monitor Closely): - Antacids containing magnesium or aluminum: may affect electrolyte balance. - Oral rehydration solutions: monitor for cumulative electrolyte load.